Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The etiology of pulmonary fibrosis is unknown. Analysis of blood, genomic DNA, and specimens procured by bronchoscopy, lung biopsy, lung transplantation, or post-mortem examination from individuals with this disorder may contribute to our understanding of pathogenic mechanisms of pulmonary fibrosis. The purpose of this protocol is to obtain blood, genomic DNA, and specimens by bronchoscopy, lung biopsy, lung transplantation, or post-mortem examination from subjects with pulmonary fibrosis. In addition, blood, genomic DNA, as well as bronchoscopy and post-mortem examination specimens may be obtained from relatives of subjects with familial pulmonary fibrosis or healthy research volunteers.
| Condition |
|---|
|
Pulmonary Fibrosis |
| Study Type: | Observational |
| Official Title: | Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis |
| Estimated Enrollment: | 500 |
| Study Start Date: | June 2004 |
The etiology of pulmonary fibrosis is unknown. Analyses of blood, genomic DNA, and specimens procured by bronchoscopy, lung biopsy, lung transplantation, or post-mortem examination from individuals with this disorder may contribute to our understanding of the pathogenic mechanisms of pulmonary fibrosis. The purpose of this protocol is to procure and analyze blood, genomic DNA, and specimens by bronchoscopy, lung biopsy, lung transplantation, or post-mortem examination from subjects with pulmonary fibrosis. In addition, blood, genomic DNA, as well as bronchoscopy and post-mortem examination specimens may be procured and analyzed from relatives of subjects with familial pulmonary fibrosis or healthy research volunteers.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
- INCLUSION CRITERIA:
Individuals who are 18 years of age or older with any of the following:
Idiopathic pulmonary fibrosis (defined by either an open lung biopsy demonstrating pulmonary fibrosis and/or HRCT scan findings consistent with idiopathic pulmonary fibrosis as outlined by the American Thoracic Society/European Respiratory Society guidelines),
Familial pulmonary fibrosis (defined as idiopathic pulmonary fibrosis in two or more first-degree relatives)
Relatives of patients with hereditary pulmonary fibrosis,
Hermansky-Pudlak syndrome (diagnosed by paucity or deficiency of platelet dense bodies on whole mount electron microscopy),
Pulmonary fibrosis associated with rheumatoid arthritis [defined by 1987 American College of Rheumatology Revised Criteria for the Classification of RA], or
Healthy research volunteers by history and indicated tests (individuals without history of chronic pulmonary disorder, collagen vascular disease, or bleeding disorder).
EXCLUSION CRITERIA:
Individuals with any of the following:
Significant Inhalational exposure to fibrogenic fibers or dusts (i.e., asbestos, silica, coal, beryllium) or exposure to drugs associated with pulmonary fibrosis,
Uncontrolled ischemic heart disease,
Other collagen vascular disorders (i.e. systemic lupus erythematosus, scleroderma, polymyositis, mixed connective tissue disease),
Uncontrolled ischemic heart disease
Other collagen vascular disorders (i.e., systemic lupus erythematosus, scleroderma, polymyositis, mixed connective tissue disease)
Uncorrectable bleeding diathesis,
Pregnancy or lactation, or
Inability to give informed consent.
Contacts and Locations| Contact: Bernadette R Gochuico, M.D. | (301) 451-7979 | gochuicb@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Bernadette R Gochuico, M.D. | National Human Genome Research Institute (NHGRI) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00084305 History of Changes |
| Other Study ID Numbers: | 040211, 04-HG-0211 |
| Study First Received: | June 9, 2004 |
| Last Updated: | August 11, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Bronchoscopy Pulmonary Fibrosis Lung Biopsy (Clinically-Indicated) |
Hereditary Pulmonary Fibrosis Healthy Volunteer HV |
Additional relevant MeSH terms:
|
Fibrosis Pulmonary Fibrosis Pathologic Processes Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 19, 2013